4164 Body mass index, not chemotherapy is the major predictor of insulin resistance in patients with hematological malignancies

4164 Body mass index, not chemotherapy is the major predictor of insulin resistance in patients with hematological malignancies

OBJECTIVES/GOALS: Cancer survivors are at increased risk for type 2 diabetes mellitus.It is not clear if diabetes susceptibility is due to shared risk factors for cancer and diabetes, such as obesity, or if it is directly related to cancer and its treatment. We investigated the association between m...

Full description

Bibliographic Details
Main Authors: Melis Sahinoz, Brian Engelhardt, Dae Kwang Jung, James Matthew Luther, Talat Alp Ikizler
Format: Article
Language:English
Published: Cambridge University Press 2020-06-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866120003726/type/journal_article

Similar Items

Similar Items